Panwen W. Tian
State Key Laboratory Of Respiratory Health And Multimorbidity, Precision Medicine Key Laboratory Of Sichuan Province
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications
International Consensus on Severe Lung Cancer-The Second Edition.
Journal: Translational lung cancer research
Published: March 21, 2026
Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study.
Journal: Future oncology (London, England)
Published: October 30, 2025
Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib.
Journal: NPJ precision oncology
Published: August 29, 2025
Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study.
Journal: Signal transduction and targeted therapy
Published: August 25, 2025
IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review).
Journal: International journal of oncology
Published: August 05, 2025
Molecular testing, treatment patterns, and outcomes in EGFR-mutated non-small cell lung cancer: the PISCES study.
Journal: Future oncology (London, England)
Published: July 28, 2025
Association of peripheral-blood neutrophil-to-lymphocyte ratio with Pneumocystis jirovecii pneumonia in patients with solid tumors: a case-control study.
Journal: Journal of thoracic disease
Published: June 27, 2025
Cancer-associated fibroblast-derived extracellular vesicles deliver ATP6V1C1 to promote lung adenocarcinoma metastasis via the ID1-IGFBP3 axis.
Journal: Cell reports
Published: June 23, 2025
Last Updated: 09/26/2026